Howard A. Fine

Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme.

P. Wen, P. Black, H. Kooy, 1995, Neurosurgery.

Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas.

Timothy F Cloughesy, Mark R Gilbert, Patrick Y Wen, 2008, Neuro-oncology.

NABTC phase I/II trial of ZD-1839 for recurrent malignant gliomas and unresectable meningiomas.

M. Prados, F. Lieberman, P. Wen, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Results of stereotactic brachytherapy used in the initial management of patients with glioblastoma.

P. Wen, H. Kooy, C. Coleman, 1990, Journal of the National Cancer Institute.

Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma

Susan M. Chang, K. Aldape, M. Prados, 2009, Journal of Neuro-Oncology.

Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?

W. Yung, M. Prados, M. Gilbert, 2011, Neuro-oncology.